Chad Michael Brummett MD

Dr. Brummett is the Director of the Division of Pain Research and, more broadly, is the Director of Clinical Research in the Department of Anesthesiology. His interests include predictors of chronic post-surgical pain as well as failure to derive benefit from interventions and surgeries done primarily for pain. In particular, Dr. Brummett is interested in the impact of a fibromyalgia-like or centralized pain phenotype on surgical outcomes and prediction of response to interventions for chronic pain (e.g. Epidural steroid and facet injections). He also leads an institution-wide initiative to create a biorepository for research of genetic factors associated with the development of disease and response to treatment. In addition, Dr. Brummett was the first to describe the use of peripheral perineural dexmedetomidine, and his early research focused on the efficacy, safety, and mechanisms of dexmedetomidine added to local anesthetics for peripheral nerve blocks. He has since translated that work to humans.